Veru Stock News

Veru (VERU) stock is rising higher on Wednesday following a recent ruling from the FDA concerning the company's Covid-19 treatment. The post VERU Stock Pops on a Covid-19 Treatment Milestone appeared

Could these health care stocks be the remedy to investors' recent stock market pains?

Veru Inc. (VERU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A short-seller makes some worrying accusations against the company.

Short squeeze stocks are once again in focus this week as Fintel released its weekly Short Squeeze Leaderboard report. Let's take a look.

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

Benjamin Graham, the father of value investing, recommended investors look for stocks that have a current ratio higher than 2 and more working capital than long-term debt.

Things are looking up with a new drug launch and some great late-stage data.

Its drug for severe COVID-19 could be a smash hit, based on recent clinical trial findings.

Wall Street is growing more bullish on the biotech's prospects.

Wall Street is growing more bullish on the biotech's prospects.

Investors sold on the news that the company said its COVID-19 therapy was safe and effective against all variants.

Veru Inc (NASDAQ: VERU) shot up 235% at one point on Monday before closing the trading session up more than 180% off Friday’s closing price. On Tuesday, the stock was consolidating the move higher

Investors sold on the news that the company said its COVID-19 therapy was safe and effective against all variants.

Veru Inc (NASDAQ: VERU) shot up 235% at one point on Monday before closing the trading session up more than 180% off Friday's closing price. On Tuesday, the stock was consolidating the move higher by